亚临床甲减的临床试验
总计534个结果
-
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy招聘中
-
The Second Affiliated Hospital of Jiaxing University邀请报名
-
Kerman University of Medical Sciences完全的
-
University of Colorado, DenverCharite University, Berlin, Germany终止
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...招聘中
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Alexion Pharmaceuticals撤销肾移植中亚临床急性抗体介导的排斥反应
-
Hospital de Clinicas de Porto AlegreSecretaria Estadual da Saúde do Estado do Rio Grande do Sul; Programa de Pesquisa e Pós-Graduação... 和其他合作者完全的
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul未知
-
Northeastern UniversityFlorida State University; Florida A&M University尚未招聘
-
Prof. Eldad YechiamBeer Yaakov - Ness Ziona Mental Health Center完全的
-
King Edward Medical University招聘中
-
University of Texas Southwestern Medical CenterAkrimax Pharmaceuticals终止
-
Shanghai 10th People's Hospital尚未招聘
-
M. MediciZonMw: The Netherlands Organisation for Health Research and Development; ACE Pharmaceuticals BV招聘中
-
Medical University of WarsawInstitute of Cardiology, Warsaw, Poland完全的甲亢/甲状腺毒症 | 甲状腺机能亢进;甲状腺肿大 | 碘诱发的甲状腺毒症 | 对比剂不良反应 | 其他特定来源的甲状腺毒症
-
OMER B ABDELBASIT完全的
-
Aga Khan University Hospital, Pakistan完全的
-
Baylor College of MedicineEli Lilly and Company; TAP Pharmaceutical Products Inc.终止